

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.04800270 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.04800270 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74965433 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.74965433 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.46722965 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11171922 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.95271597 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.95271597 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.95271597 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.82972021 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.63220619 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.62429702 |
| 13 | urea metabolic process (GO:0019627) | 5.55612058 |
| 14 | urea cycle (GO:0000050) | 5.55612058 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.52878247 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.43240894 |
| 17 | cysteine metabolic process (GO:0006534) | 5.33701168 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.32121037 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30531112 |
| 20 | protein carboxylation (GO:0018214) | 5.24085016 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24085016 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.24081706 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.20760009 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.09822923 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.06745843 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.02880979 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97462316 |
| 28 | * bile acid metabolic process (GO:0008206) | 4.83844762 |
| 29 | serine family amino acid catabolic process (GO:0009071) | 4.81824394 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.79442204 |
| 31 | regulation of complement activation (GO:0030449) | 4.75950873 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.71222623 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.69688679 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.68349072 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.64955900 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 4.61835101 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.61835101 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.59386734 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.59386734 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.59386734 |
| 41 | phospholipid efflux (GO:0033700) | 4.55017982 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.54135451 |
| 43 | cellular glucuronidation (GO:0052695) | 4.52777820 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.48475706 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.46460125 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.46460125 |
| 47 | lysine catabolic process (GO:0006554) | 4.45047397 |
| 48 | lysine metabolic process (GO:0006553) | 4.45047397 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.36445830 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.34156531 |
| 51 | * bile acid and bile salt transport (GO:0015721) | 4.32069675 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.28860129 |
| 53 | cholesterol efflux (GO:0033344) | 4.22291169 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.19578719 |
| 55 | benzene-containing compound metabolic process (GO:0042537) | 4.11219737 |
| 56 | cellular biogenic amine catabolic process (GO:0042402) | 4.11162955 |
| 57 | amine catabolic process (GO:0009310) | 4.11162955 |
| 58 | ethanol oxidation (GO:0006069) | 4.06502102 |
| 59 | glucuronate metabolic process (GO:0019585) | 4.05324430 |
| 60 | uronic acid metabolic process (GO:0006063) | 4.05324430 |
| 61 | cellular amino acid catabolic process (GO:0009063) | 4.05144612 |
| 62 | glycine metabolic process (GO:0006544) | 4.04568111 |
| 63 | glutamate metabolic process (GO:0006536) | 4.04344389 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 4.03975217 |
| 65 | plasma lipoprotein particle assembly (GO:0034377) | 4.00908143 |
| 66 | drug catabolic process (GO:0042737) | 4.00589898 |
| 67 | coenzyme catabolic process (GO:0009109) | 3.99519784 |
| 68 | low-density lipoprotein particle remodeling (GO:0034374) | 3.96037071 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 3.95384585 |
| 70 | daunorubicin metabolic process (GO:0044597) | 3.94801907 |
| 71 | polyketide metabolic process (GO:0030638) | 3.94801907 |
| 72 | doxorubicin metabolic process (GO:0044598) | 3.94801907 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 3.91196840 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.86172806 |
| 75 | fibrinolysis (GO:0042730) | 3.84291918 |
| 76 | response to nitrosative stress (GO:0051409) | 3.83306426 |
| 77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75310430 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.73864474 |
| 79 | cholesterol homeostasis (GO:0042632) | 3.73084224 |
| 80 | regulation of cholesterol homeostasis (GO:2000188) | 3.72515630 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.72057205 |
| 82 | complement activation, classical pathway (GO:0006958) | 3.71881275 |
| 83 | negative regulation of lipase activity (GO:0060192) | 3.71794239 |
| 84 | arginine metabolic process (GO:0006525) | 3.71130493 |
| 85 | ketone body metabolic process (GO:1902224) | 3.69341094 |
| 86 | flavonoid metabolic process (GO:0009812) | 3.68974601 |
| 87 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68564163 |
| 88 | complement activation (GO:0006956) | 3.68327350 |
| 89 | sterol homeostasis (GO:0055092) | 3.67591115 |
| 90 | positive regulation of lipid catabolic process (GO:0050996) | 3.65860614 |
| 91 | protein-lipid complex assembly (GO:0065005) | 3.65858472 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64260693 |
| 93 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64260693 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.64217870 |
| 95 | protein activation cascade (GO:0072376) | 3.59590972 |
| 96 | organic acid catabolic process (GO:0016054) | 3.59394563 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.59394563 |
| 98 | cofactor catabolic process (GO:0051187) | 3.57972291 |
| 99 | desmosome organization (GO:0002934) | 3.57697669 |
| 100 | plasma lipoprotein particle organization (GO:0071827) | 3.55375306 |
| 101 | mannose metabolic process (GO:0006013) | 3.54725678 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.51995938 |
| 103 | lipoprotein metabolic process (GO:0042157) | 3.49231857 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47443513 |
| 105 | intestinal cholesterol absorption (GO:0030299) | 3.47022588 |
| 106 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.45403393 |
| 107 | negative regulation of hemostasis (GO:1900047) | 3.40056470 |
| 108 | negative regulation of blood coagulation (GO:0030195) | 3.40056470 |
| 109 | epoxygenase P450 pathway (GO:0019373) | 3.37931716 |
| 110 | semaphorin-plexin signaling pathway (GO:0071526) | 3.35176594 |
| 111 | regulation of plasminogen activation (GO:0010755) | 3.34866811 |
| 112 | drug transmembrane transport (GO:0006855) | 3.30522735 |
| 113 | hemidesmosome assembly (GO:0031581) | 3.29404340 |
| 114 | negative regulation of coagulation (GO:0050819) | 3.26815412 |
| 115 | primary alcohol catabolic process (GO:0034310) | 3.11216201 |
| 116 | intestinal absorption (GO:0050892) | 3.08899573 |
| 117 | exogenous drug catabolic process (GO:0042738) | 3.06951730 |
| 118 | negative regulation of wound healing (GO:0061045) | 3.05626784 |
| 119 | positive regulation of blood coagulation (GO:0030194) | 3.05513534 |
| 120 | positive regulation of hemostasis (GO:1900048) | 3.05513534 |
| 121 | regulation of apoptotic cell clearance (GO:2000425) | 3.05471413 |
| 122 | drug transport (GO:0015893) | 2.97597442 |
| 123 | epithelial cell-cell adhesion (GO:0090136) | 2.93108284 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 2.92569714 |
| 125 | positive regulation of extracellular matrix organization (GO:1903055) | 2.88722700 |
| 126 | positive regulation of coagulation (GO:0050820) | 2.88576721 |
| 127 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.86117019 |
| 128 | progesterone metabolic process (GO:0042448) | 2.80228137 |
| 129 | omega-hydroxylase P450 pathway (GO:0097267) | 2.77825099 |
| 130 | thrombin receptor signaling pathway (GO:0070493) | 2.75019427 |
| 131 | acute-phase response (GO:0006953) | 2.68571432 |
| 132 | sulfate transmembrane transport (GO:1902358) | 2.68042239 |
| 133 | drug metabolic process (GO:0017144) | 2.67839837 |
| 134 | mesodermal cell differentiation (GO:0048333) | 2.66230805 |
| 135 | regulation of integrin activation (GO:0033623) | 2.65188776 |
| 136 | glycoside metabolic process (GO:0016137) | 2.65151383 |
| 137 | peptide catabolic process (GO:0043171) | 2.59699083 |
| 138 | ethanol metabolic process (GO:0006067) | 2.54935059 |
| 139 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.54358084 |
| 140 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.52174761 |
| 141 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.49014760 |
| 142 | negative regulation of protein activation cascade (GO:2000258) | 2.48611186 |
| 143 | lung epithelium development (GO:0060428) | 2.48137827 |
| 144 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.48123817 |
| 145 | actin filament depolymerization (GO:0030042) | 2.47579549 |
| 146 | negative regulation of lipid transport (GO:0032369) | 2.45205498 |
| 147 | regulation of hemostasis (GO:1900046) | 2.44120899 |
| 148 | regulation of blood coagulation (GO:0030193) | 2.44120899 |
| 149 | renal filtration (GO:0097205) | 2.43929304 |
| 150 | lung vasculature development (GO:0060426) | 2.43528974 |
| 151 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.43241542 |
| 152 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42781462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94141141 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88066677 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.49673841 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.28456398 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.77601332 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.02214262 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.61235483 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.58933372 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.85139466 |
| 10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.53890686 |
| 11 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.24248774 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.17779323 |
| 13 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.03941150 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1125814 |
| 15 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93817446 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93692586 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87073851 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74363640 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.68497769 |
| 20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.66168199 |
| 21 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64934076 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.64595469 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60465586 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59943801 |
| 25 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.59679927 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56375464 |
| 27 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.48347000 |
| 28 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.48084299 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47983333 |
| 30 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40754054 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37798395 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36804645 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34890017 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.33215123 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.33025414 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33006392 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32200031 |
| 38 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31851961 |
| 39 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30295287 |
| 40 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30295287 |
| 41 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27772282 |
| 42 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.27031412 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26839942 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26083781 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25636239 |
| 46 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24513396 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.20469215 |
| 48 | P68_20966046_ChIP-Seq_HELA_Human | 1.18828887 |
| 49 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18412789 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17854373 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16346727 |
| 52 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16159417 |
| 53 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15878299 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14028089 |
| 55 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13888569 |
| 56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13537267 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13112556 |
| 58 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.13072360 |
| 59 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12976464 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12668897 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09026662 |
| 62 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08141621 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07714792 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07324972 |
| 65 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07266866 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05735339 |
| 67 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05651301 |
| 68 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.03580532 |
| 69 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03479979 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03462255 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02658215 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01737142 |
| 73 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01036226 |
| 74 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00363174 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00331156 |
| 76 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98349112 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98266166 |
| 78 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97457288 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97120524 |
| 80 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96848203 |
| 81 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96483885 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96021115 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95737010 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94767096 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92683110 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92014442 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91663215 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91191049 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89622144 |
| 90 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87856821 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83206267 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82818213 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.79930272 |
| 94 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.77904460 |
| 95 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77803043 |
| 96 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.77225857 |
| 97 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.77110590 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76909045 |
| 99 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74834899 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73444282 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.72874061 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72221990 |
| 103 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71866870 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71844405 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71844405 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71325464 |
| 107 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.70664456 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.68772262 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68650349 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.68539830 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66137094 |
| 112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64342072 |
| 113 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.64290572 |
| 114 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.63766637 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63496466 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62899447 |
| 117 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.62651890 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.62304366 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62163049 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61474585 |
| 121 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.61435693 |
| 122 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60275703 |
| 123 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58865211 |
| 124 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57969686 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57742702 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57528172 |
| 127 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.57093657 |
| 128 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55541695 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53742203 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53129860 |
| 131 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.52921274 |
| 132 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.52131096 |
| 133 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.51975102 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51901489 |
| 135 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51694839 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.51493721 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51078817 |
| 138 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.51038518 |
| 139 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50036889 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.49718104 |
| 141 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49380478 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49119034 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.49011347 |
| 144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.48446447 |
| 145 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.46773040 |
| 146 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.46325076 |
| 147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.46000499 |
| 148 | CBP_21632823_ChIP-Seq_H3396_Human | 0.44360361 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.44254320 |
| 150 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43376120 |
| 151 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.43352336 |
| 152 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43029069 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42846191 |
| 154 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.42758525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.95863776 |
| 2 | MP0005360_urolithiasis | 7.27740270 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.23037141 |
| 4 | * MP0005365_abnormal_bile_salt | 5.72821341 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.95137032 |
| 6 | MP0003252_abnormal_bile_duct | 4.00219626 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.85320860 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.51623072 |
| 9 | MP0009840_abnormal_foam_cell | 3.42593622 |
| 10 | MP0005083_abnormal_biliary_tract | 2.99724493 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.75194107 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.65511778 |
| 13 | MP0005332_abnormal_amino_acid | 2.61863384 |
| 14 | MP0003195_calcinosis | 2.54153425 |
| 15 | MP0001849_ear_inflammation | 2.46808877 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.30322847 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.18470322 |
| 18 | MP0003566_abnormal_cell_adhesion | 2.18202484 |
| 19 | MP0000609_abnormal_liver_physiology | 2.18089642 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.06932743 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.02474557 |
| 22 | MP0005023_abnormal_wound_healing | 1.99018028 |
| 23 | MP0003868_abnormal_feces_composition | 1.85197602 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.81846926 |
| 25 | MP0001764_abnormal_homeostasis | 1.55540553 |
| 26 | MP0004272_abnormal_basement_membrane | 1.53304102 |
| 27 | MP0001958_emphysema | 1.53145390 |
| 28 | MP0000858_altered_metastatic_potential | 1.52676742 |
| 29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52627733 |
| 30 | MP0005451_abnormal_body_composition | 1.49211238 |
| 31 | MP0005257_abnormal_intraocular_pressure | 1.43241802 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.32131932 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.31813989 |
| 34 | MP0003011_delayed_dark_adaptation | 1.30494026 |
| 35 | MP0009697_abnormal_copulation | 1.28670660 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.27695196 |
| 37 | MP0003186_abnormal_redox_activity | 1.27455998 |
| 38 | MP0003279_aneurysm | 1.25107753 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.24806547 |
| 40 | MP0001664_abnormal_digestion | 1.24561548 |
| 41 | MP0003091_abnormal_cell_migration | 1.23621242 |
| 42 | MP0000598_abnormal_liver_morphology | 1.18906626 |
| 43 | MP0002254_reproductive_system_inflammat | 1.18818273 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.17743136 |
| 45 | MP0000604_amyloidosis | 1.17158337 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.15150167 |
| 47 | MP0005647_abnormal_sex_gland | 1.14708588 |
| 48 | MP0009764_decreased_sensitivity_to | 1.12776010 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.11081558 |
| 50 | MP0000467_abnormal_esophagus_morphology | 1.09554375 |
| 51 | MP0005409_darkened_coat_color | 1.09483266 |
| 52 | MP0009763_increased_sensitivity_to | 1.04638003 |
| 53 | MP0000566_synostosis | 1.03720795 |
| 54 | MP0008469_abnormal_protein_level | 1.02885103 |
| 55 | MP0004510_myositis | 1.01164304 |
| 56 | MP0008260_abnormal_autophagy | 1.00515136 |
| 57 | MP0000003_abnormal_adipose_tissue | 0.99289310 |
| 58 | MP0003879_abnormal_hair_cell | 0.99016941 |
| 59 | MP0005058_abnormal_lysosome_morphology | 0.96571658 |
| 60 | MP0002089_abnormal_postnatal_growth/wei | 0.94288902 |
| 61 | MP0002933_joint_inflammation | 0.93514240 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.93205852 |
| 63 | MP0000537_abnormal_urethra_morphology | 0.89833821 |
| 64 | MP0001663_abnormal_digestive_system | 0.89356547 |
| 65 | MP0002060_abnormal_skin_morphology | 0.89109194 |
| 66 | MP0001216_abnormal_epidermal_layer | 0.88560934 |
| 67 | MP0001765_abnormal_ion_homeostasis | 0.88005402 |
| 68 | MP0010368_abnormal_lymphatic_system | 0.87834464 |
| 69 | * MP0009642_abnormal_blood_homeostasis | 0.87675571 |
| 70 | MP0003690_abnormal_glial_cell | 0.87427901 |
| 71 | MP0005375_adipose_tissue_phenotype | 0.87214124 |
| 72 | MP0005501_abnormal_skin_physiology | 0.86079258 |
| 73 | MP0000343_altered_response_to | 0.83826408 |
| 74 | MP0006082_CNS_inflammation | 0.82282201 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.81939865 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.81858962 |
| 77 | MP0005595_abnormal_vascular_smooth | 0.81580343 |
| 78 | MP0005670_abnormal_white_adipose | 0.81208674 |
| 79 | MP0005408_hypopigmentation | 0.81151721 |
| 80 | MP0000538_abnormal_urinary_bladder | 0.80217867 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.79546663 |
| 82 | MP0005165_increased_susceptibility_to | 0.78776664 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.78238838 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.78159914 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.77735050 |
| 86 | MP0003866_abnormal_defecation | 0.77126749 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.76852404 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.76703951 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.76519105 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.75982576 |
| 91 | MP0003045_fibrosis | 0.74496853 |
| 92 | MP0001756_abnormal_urination | 0.74066576 |
| 93 | MP0000477_abnormal_intestine_morphology | 0.73276724 |
| 94 | MP0002971_abnormal_brown_adipose | 0.72390087 |
| 95 | MP0002078_abnormal_glucose_homeostasis | 0.71142066 |
| 96 | MP0003436_decreased_susceptibility_to | 0.71106454 |
| 97 | MP0004130_abnormal_muscle_cell | 0.70814177 |
| 98 | MP0005390_skeleton_phenotype | 0.70760376 |
| 99 | MP0000013_abnormal_adipose_tissue | 0.70558340 |
| 100 | MP0005334_abnormal_fat_pad | 0.69900653 |
| 101 | MP0005220_abnormal_exocrine_pancreas | 0.69071493 |
| 102 | MP0003300_gastrointestinal_ulcer | 0.68218991 |
| 103 | MP0003724_increased_susceptibility_to | 0.63502854 |
| 104 | MP0005084_abnormal_gallbladder_morpholo | 0.63310292 |
| 105 | MP0004782_abnormal_surfactant_physiolog | 0.61745078 |
| 106 | MP0005166_decreased_susceptibility_to | 0.60933974 |
| 107 | MP0009053_abnormal_anal_canal | 0.60609581 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.60604960 |
| 109 | MP0005535_abnormal_body_temperature | 0.58938391 |
| 110 | MP0006036_abnormal_mitochondrial_physio | 0.58775884 |
| 111 | MP0005266_abnormal_metabolism | 0.57831349 |
| 112 | MP0002928_abnormal_bile_duct | 0.57050748 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.56734670 |
| 114 | MP0008873_increased_physiological_sensi | 0.56116153 |
| 115 | MP0003075_altered_response_to | 0.55849272 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.53813773 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.53398697 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.53053752 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.52598077 |
| 120 | MP0005448_abnormal_energy_balance | 0.52284450 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.49723277 |
| 122 | MP0001661_extended_life_span | 0.49583962 |
| 123 | MP0005395_other_phenotype | 0.49572849 |
| 124 | MP0003329_amyloid_beta_deposits | 0.48838188 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.48220792 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.45066733 |
| 127 | MP0000249_abnormal_blood_vessel | 0.44936461 |
| 128 | MP0008874_decreased_physiological_sensi | 0.44572615 |
| 129 | MP0003718_maternal_effect | 0.44084897 |
| 130 | MP0009384_cardiac_valve_regurgitation | 0.41818687 |
| 131 | MP0004947_skin_inflammation | 0.39872103 |
| 132 | MP0002796_impaired_skin_barrier | 0.38746670 |
| 133 | MP0009115_abnormal_fat_cell | 0.38500043 |
| 134 | MP0001853_heart_inflammation | 0.38416117 |
| 135 | MP0002419_abnormal_innate_immunity | 0.37650067 |
| 136 | MP0004883_abnormal_blood_vessel | 0.37385165 |
| 137 | MP0003953_abnormal_hormone_level | 0.37310803 |
| 138 | MP0002168_other_aberrant_phenotype | 0.37048432 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.36833674 |
| 140 | MP0008004_abnormal_stomach_pH | 0.36806984 |
| 141 | MP0003453_abnormal_keratinocyte_physiol | 0.36123992 |
| 142 | MP0005164_abnormal_response_to | 0.35120005 |
| 143 | MP0001243_abnormal_dermal_layer | 0.34011819 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.33880306 |
| 145 | MP0010155_abnormal_intestine_physiology | 0.33837929 |
| 146 | MP0003303_peritoneal_inflammation | 0.33382432 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.32489855 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.08618358 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.03140148 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.85669032 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.51211499 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.21818606 |
| 6 | Xanthomatosis (HP:0000991) | 6.18373857 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.17940879 |
| 8 | Complement deficiency (HP:0004431) | 5.71906939 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.22711765 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.69445405 |
| 11 | Joint hemorrhage (HP:0005261) | 4.66141794 |
| 12 | Epidermoid cyst (HP:0200040) | 4.50032124 |
| 13 | Hyperammonemia (HP:0001987) | 4.36293556 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.30497282 |
| 15 | Abnormality of complement system (HP:0005339) | 4.26886907 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.23644262 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.18684572 |
| 18 | Fat malabsorption (HP:0002630) | 4.17954404 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16093375 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.10977786 |
| 21 | Hyperglycinemia (HP:0002154) | 4.08602905 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 3.99166793 |
| 23 | Ketosis (HP:0001946) | 3.96892700 |
| 24 | Cervical subluxation (HP:0003308) | 3.96854890 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.95370035 |
| 26 | J-shaped sella turcica (HP:0002680) | 3.85005282 |
| 27 | Hyperglycinuria (HP:0003108) | 3.82614064 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.80976870 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.76656775 |
| 30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.71017081 |
| 31 | Abnormality of glycine metabolism (HP:0010895) | 3.71017081 |
| 32 | Broad face (HP:0000283) | 3.70287201 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.68673956 |
| 34 | Abnormality of the intrinsic pathway (HP:0010989) | 3.65385607 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.64784930 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.56840953 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.56840953 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.56488377 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.54561983 |
| 40 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.47150659 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.47150659 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.47150659 |
| 43 | Myocardial infarction (HP:0001658) | 3.28925981 |
| 44 | Glomerulonephritis (HP:0000099) | 3.26636127 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.25259519 |
| 46 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.24570428 |
| 47 | Purpura (HP:0000979) | 3.22671037 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.14519218 |
| 49 | Steatorrhea (HP:0002570) | 3.10838142 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 3.03827491 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03434359 |
| 52 | Focal segmental glomerulosclerosis (HP:0000097) | 2.98412098 |
| 53 | Increased mean platelet volume (HP:0011877) | 2.95740666 |
| 54 | Thin bony cortex (HP:0002753) | 2.92603806 |
| 55 | Hepatocellular carcinoma (HP:0001402) | 2.89535121 |
| 56 | Flat acetabular roof (HP:0003180) | 2.82622726 |
| 57 | Skin nodule (HP:0200036) | 2.82242596 |
| 58 | Ketoacidosis (HP:0001993) | 2.80292729 |
| 59 | Abnormality of purine metabolism (HP:0004352) | 2.76907350 |
| 60 | Protrusio acetabuli (HP:0003179) | 2.75598419 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.75218443 |
| 62 | Abnormality of serum amino acid levels (HP:0003112) | 2.74219237 |
| 63 | Acanthocytosis (HP:0001927) | 2.68942129 |
| 64 | Spontaneous abortion (HP:0005268) | 2.66720623 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.66680102 |
| 66 | Vascular calcification (HP:0004934) | 2.66576339 |
| 67 | Hypochromic microcytic anemia (HP:0004840) | 2.64036779 |
| 68 | Metabolic acidosis (HP:0001942) | 2.61672544 |
| 69 | Esophageal varix (HP:0002040) | 2.57453793 |
| 70 | Glomerulosclerosis (HP:0000096) | 2.57219827 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56662008 |
| 72 | Nuclear cataract (HP:0100018) | 2.55835514 |
| 73 | Atrophic scars (HP:0001075) | 2.53377838 |
| 74 | Malnutrition (HP:0004395) | 2.51406184 |
| 75 | Distal upper limb amyotrophy (HP:0007149) | 2.50661183 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.50661183 |
| 77 | Gout (HP:0001997) | 2.45845135 |
| 78 | Cholecystitis (HP:0001082) | 2.43820068 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.43820068 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.42248168 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40358797 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.40358797 |
| 83 | Amyloidosis (HP:0011034) | 2.40349716 |
| 84 | Spastic diplegia (HP:0001264) | 2.39559985 |
| 85 | Abnormality of glycolipid metabolism (HP:0010969) | 2.38771313 |
| 86 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.38771313 |
| 87 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.38771313 |
| 88 | Joint stiffness (HP:0001387) | 2.37220476 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.36253420 |
| 90 | Lethargy (HP:0001254) | 2.36030847 |
| 91 | Cardiovascular calcification (HP:0011915) | 2.35676883 |
| 92 | Short nail (HP:0001799) | 2.35470541 |
| 93 | Mitral stenosis (HP:0001718) | 2.33690797 |
| 94 | Cholelithiasis (HP:0001081) | 2.31799627 |
| 95 | Cerebral aneurysm (HP:0004944) | 2.28169661 |
| 96 | Epistaxis (HP:0000421) | 2.27297501 |
| 97 | Sensorimotor neuropathy (HP:0007141) | 2.26281660 |
| 98 | Nephritis (HP:0000123) | 2.25312672 |
| 99 | Aortic regurgitation (HP:0001659) | 2.25206128 |
| 100 | Fragile skin (HP:0001030) | 2.24305842 |
| 101 | Premature rupture of membranes (HP:0001788) | 2.23413916 |
| 102 | Petechiae (HP:0000967) | 2.23212688 |
| 103 | Abnormality of the Achilles tendon (HP:0005109) | 2.22759523 |
| 104 | Irritability (HP:0000737) | 2.22482496 |
| 105 | Stridor (HP:0010307) | 2.22283131 |
| 106 | Hypoglycemic seizures (HP:0002173) | 2.20383695 |
| 107 | Menorrhagia (HP:0000132) | 2.20119648 |
| 108 | Gingival bleeding (HP:0000225) | 2.18838042 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 2.17703542 |
| 110 | Hemorrhage of the eye (HP:0011885) | 2.17621247 |
| 111 | Abdominal distention (HP:0003270) | 2.17365782 |
| 112 | Pancreatitis (HP:0001733) | 2.14439814 |
| 113 | Arterial tortuosity (HP:0005116) | 2.10061329 |
| 114 | Late onset (HP:0003584) | 2.10060844 |
| 115 | Increased serum ferritin (HP:0003281) | 2.07281644 |
| 116 | Neonatal onset (HP:0003623) | 2.07018055 |
| 117 | Ulnar bowing (HP:0003031) | 2.06313759 |
| 118 | Vertebral compression fractures (HP:0002953) | 2.02691399 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 2.01853214 |
| 120 | Hydroxyprolinuria (HP:0003080) | 2.01853214 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 2.01624474 |
| 122 | Poikilocytosis (HP:0004447) | 2.00710561 |
| 123 | Thrombophlebitis (HP:0004418) | 1.99612487 |
| 124 | Deformed sella turcica (HP:0002681) | 1.98664506 |
| 125 | Cerebral edema (HP:0002181) | 1.96817319 |
| 126 | Axonal loss (HP:0003447) | 1.94501796 |
| 127 | Brushfield spots (HP:0001088) | 1.93096575 |
| 128 | Abnormality of the gallbladder (HP:0005264) | 1.92691064 |
| 129 | Vascular tortuosity (HP:0004948) | 1.92647445 |
| 130 | Rickets (HP:0002748) | 1.92479836 |
| 131 | Enlarged kidneys (HP:0000105) | 1.92069984 |
| 132 | Vomiting (HP:0002013) | 1.91912741 |
| 133 | Increased cerebral lipofuscin (HP:0011813) | 1.91396437 |
| 134 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90597137 |
| 135 | Abnormal cartilage morphology (HP:0002763) | 1.90490020 |
| 136 | Protuberant abdomen (HP:0001538) | 1.90185761 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.89753825 |
| 138 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89143369 |
| 139 | Aneurysm (HP:0002617) | 1.88977904 |
| 140 | Biconcave vertebral bodies (HP:0004586) | 1.88496174 |
| 141 | Hyperacusis (HP:0010780) | 1.88200833 |
| 142 | Upper motor neuron abnormality (HP:0002127) | 1.86349625 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.86282306 |
| 144 | Elevated alkaline phosphatase (HP:0003155) | 1.84635637 |
| 145 | Opisthotonus (HP:0002179) | 1.84583034 |
| 146 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83976089 |
| 147 | Alkalosis (HP:0001948) | 1.83293364 |
| 148 | Abnormal hair laboratory examination (HP:0003328) | 1.82459202 |
| 149 | Aortic aneurysm (HP:0004942) | 1.81842241 |
| 150 | Prolonged neonatal jaundice (HP:0006579) | 1.81790494 |
| 151 | Abnormal platelet function (HP:0011869) | 1.80144530 |
| 152 | Impaired platelet aggregation (HP:0003540) | 1.80144530 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.79953707 |
| 154 | Milia (HP:0001056) | 1.78761432 |
| 155 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.78011311 |
| 156 | Bone pain (HP:0002653) | 1.76279411 |
| 157 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76091783 |
| 158 | Cerebral palsy (HP:0100021) | 1.75619274 |
| 159 | Long toe (HP:0010511) | 1.73890881 |
| 160 | Stroke (HP:0001297) | 1.71860116 |
| 161 | Elevated hepatic transaminases (HP:0002910) | 1.70809539 |
| 162 | Hypophosphatemic rickets (HP:0004912) | 1.70655392 |
| 163 | Increased purine levels (HP:0004368) | 1.70137401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.61896033 |
| 2 | ERN1 | 4.27951516 |
| 3 | LMTK2 | 4.24121455 |
| 4 | FGFR4 | 3.81915432 |
| 5 | SIK1 | 3.78418548 |
| 6 | TAOK3 | 3.23164162 |
| 7 | ERBB4 | 2.61733938 |
| 8 | MST1R | 2.59200603 |
| 9 | INSRR | 2.42613152 |
| 10 | FRK | 2.38043175 |
| 11 | PKN2 | 2.16174070 |
| 12 | TGFBR2 | 2.07866830 |
| 13 | TYK2 | 2.04746292 |
| 14 | PDGFRA | 2.01177173 |
| 15 | MAP2K4 | 1.94996505 |
| 16 | LATS1 | 1.78137324 |
| 17 | TRIB3 | 1.76599270 |
| 18 | MAP2K3 | 1.74563604 |
| 19 | PTK6 | 1.73032169 |
| 20 | PIK3CG | 1.71447117 |
| 21 | MAPK11 | 1.63381806 |
| 22 | NTRK1 | 1.59087694 |
| 23 | DDR2 | 1.59013625 |
| 24 | TBK1 | 1.54522813 |
| 25 | FLT3 | 1.48864977 |
| 26 | NEK9 | 1.46677611 |
| 27 | MAPK15 | 1.44711946 |
| 28 | EPHB2 | 1.41824843 |
| 29 | PAK4 | 1.36848159 |
| 30 | CAMK1D | 1.35621426 |
| 31 | IRAK3 | 1.34720860 |
| 32 | JAK1 | 1.25041684 |
| 33 | TTN | 1.24120848 |
| 34 | JAK2 | 1.23776156 |
| 35 | CSF1R | 1.21377516 |
| 36 | CDC42BPA | 1.18114151 |
| 37 | PRKAA2 | 1.17516114 |
| 38 | MAP3K3 | 1.15990606 |
| 39 | DAPK2 | 1.15102083 |
| 40 | MAP3K14 | 1.14567977 |
| 41 | EPHB1 | 1.13565478 |
| 42 | KDR | 1.13412379 |
| 43 | RIPK1 | 1.12603325 |
| 44 | MATK | 1.10439941 |
| 45 | MAP3K7 | 1.10183562 |
| 46 | MYLK | 1.07646519 |
| 47 | ABL2 | 1.07097050 |
| 48 | CSK | 1.03968601 |
| 49 | ERBB2 | 1.00705498 |
| 50 | FGFR2 | 0.98985139 |
| 51 | PDGFRB | 0.97277366 |
| 52 | GRK6 | 0.97024070 |
| 53 | MAP3K10 | 0.95768174 |
| 54 | MET | 0.94286181 |
| 55 | CDK6 | 0.92537270 |
| 56 | MAP3K6 | 0.89303708 |
| 57 | PTK2B | 0.85236917 |
| 58 | MAPK4 | 0.80870949 |
| 59 | MAPK12 | 0.80816481 |
| 60 | TESK1 | 0.78859315 |
| 61 | MAP2K6 | 0.78440852 |
| 62 | CAMK1G | 0.76083936 |
| 63 | GSK3A | 0.75674837 |
| 64 | PRKD2 | 0.75538839 |
| 65 | MAP3K11 | 0.74948066 |
| 66 | EPHA2 | 0.74878299 |
| 67 | PRKCZ | 0.73581869 |
| 68 | FGR | 0.71811511 |
| 69 | MAPKAPK3 | 0.70274541 |
| 70 | IKBKE | 0.70002575 |
| 71 | MAP2K2 | 0.69030107 |
| 72 | JAK3 | 0.68586341 |
| 73 | PRKCI | 0.67198814 |
| 74 | WNK4 | 0.66859403 |
| 75 | DYRK1B | 0.63900406 |
| 76 | PTK2 | 0.63886337 |
| 77 | NUAK1 | 0.62244180 |
| 78 | RPS6KA2 | 0.62073395 |
| 79 | FER | 0.61988301 |
| 80 | PRKAA1 | 0.61721541 |
| 81 | ZAP70 | 0.61311854 |
| 82 | STK39 | 0.61207916 |
| 83 | ICK | 0.60209073 |
| 84 | PINK1 | 0.60114792 |
| 85 | MAP3K13 | 0.59350294 |
| 86 | NME2 | 0.58883829 |
| 87 | PRKACG | 0.58020848 |
| 88 | MAPK7 | 0.56952366 |
| 89 | PDPK1 | 0.56570368 |
| 90 | SGK3 | 0.55634770 |
| 91 | MAP2K1 | 0.54249614 |
| 92 | MARK2 | 0.53372203 |
| 93 | IGF1R | 0.53105515 |
| 94 | STK38L | 0.51417691 |
| 95 | EGFR | 0.50352492 |
| 96 | FGFR3 | 0.50156478 |
| 97 | KIT | 0.48710326 |
| 98 | CAMK2G | 0.48154265 |
| 99 | TIE1 | 0.47937647 |
| 100 | EPHA3 | 0.45172186 |
| 101 | IRAK1 | 0.44428654 |
| 102 | MAP4K1 | 0.44406823 |
| 103 | STK38 | 0.43640574 |
| 104 | BLK | 0.43265639 |
| 105 | MAP3K5 | 0.43149520 |
| 106 | STK3 | 0.43058480 |
| 107 | MAP3K2 | 0.42837967 |
| 108 | TAOK1 | 0.42100788 |
| 109 | IRAK2 | 0.41436434 |
| 110 | PRKCQ | 0.41330394 |
| 111 | MELK | 0.40999957 |
| 112 | IRAK4 | 0.40667567 |
| 113 | ACVR1B | 0.40656260 |
| 114 | MTOR | 0.40419771 |
| 115 | GRK1 | 0.39936648 |
| 116 | RET | 0.39665413 |
| 117 | STK10 | 0.39350282 |
| 118 | PHKG2 | 0.37686398 |
| 119 | PHKG1 | 0.37686398 |
| 120 | PDK1 | 0.37292922 |
| 121 | ILK | 0.37080089 |
| 122 | SMG1 | 0.37003307 |
| 123 | PIK3CA | 0.35597295 |
| 124 | ROCK1 | 0.35455871 |
| 125 | IKBKB | 0.35193462 |
| 126 | PRPF4B | 0.34742802 |
| 127 | MAPKAPK2 | 0.34555152 |
| 128 | ITK | 0.34184606 |
| 129 | TNK2 | 0.34117906 |
| 130 | BMX | 0.34006496 |
| 131 | PDK2 | 0.33368441 |
| 132 | SRC | 0.32961423 |
| 133 | MAP3K1 | 0.32566679 |
| 134 | TRPM7 | 0.31946929 |
| 135 | CSNK1G1 | 0.31566748 |
| 136 | RIPK4 | 0.31323072 |
| 137 | CAMK4 | 0.31311802 |
| 138 | ABL1 | 0.30345280 |
| 139 | CHUK | 0.30063997 |
| 140 | CDK9 | 0.29859413 |
| 141 | RPS6KL1 | 0.29500374 |
| 142 | RPS6KC1 | 0.29500374 |
| 143 | CDK8 | 0.29144194 |
| 144 | PRKG2 | 0.28923078 |
| 145 | PDK4 | 0.28686952 |
| 146 | PDK3 | 0.28686952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31321062 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59058872 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49087041 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09408744 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96034280 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74902934 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.66859467 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56087663 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46650558 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45469410 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44842928 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33325998 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.31762158 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29355162 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.12249282 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.10669743 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05494228 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05175757 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.00969706 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00332178 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93166202 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91357839 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89769659 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.82757924 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75848911 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.75675655 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74438216 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69098057 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66825022 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63267619 |
| 31 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.61210883 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56899049 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52637191 |
| 34 | * Bile secretion_Homo sapiens_hsa04976 | 1.48482192 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46506496 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42763831 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42665250 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38940941 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29202694 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28973607 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.28548031 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25640576 |
| 43 | * ABC transporters_Homo sapiens_hsa02010 | 1.22019842 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19788759 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18893682 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17121024 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.11349242 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08792088 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04614124 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98063533 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96242373 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93825664 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93022029 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90716505 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.90090033 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89983691 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.88180154 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86503123 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85221371 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.84518532 |
| 61 | Focal adhesion_Homo sapiens_hsa04510 | 0.84320391 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.83403207 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81914228 |
| 64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81143189 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81135485 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72885682 |
| 67 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.71164797 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70142935 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66713873 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62949745 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60931674 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60686026 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60625324 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.59121275 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57757044 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53564103 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52048468 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51316910 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50013311 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.47480011 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42855812 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.41867068 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41487739 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41337665 |
| 85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41058675 |
| 86 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39310146 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38989258 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37591816 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35497488 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.34813014 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.33668485 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33438691 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33342641 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33102158 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33052962 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32988154 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32381875 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32022118 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.31710298 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31692612 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.30448409 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30196383 |
| 103 | Malaria_Homo sapiens_hsa05144 | 0.30098142 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29061824 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28969855 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28326363 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.27671325 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27397701 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24946815 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24105014 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21721602 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05244188 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03455355 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.01123435 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.00661749 |
| 116 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1745163 |
| 117 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.1743070 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | -0.1655724 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1476010 |
| 120 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1424288 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | -0.1344656 |
| 122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1264555 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1246220 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1217084 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1109109 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | -0.0689840 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0661223 |
| 128 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0441548 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | -0.0350982 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0274593 |
| 131 | Pertussis_Homo sapiens_hsa05133 | -0.0097266 |
| 132 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0081391 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0039319 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0025627 |

